Potentiating the Radiation-Induced Type I Interferon Anti-Tumoral Immune Response by ATM Inhibition in Pancreatic Cancer

The authors evaluated the effects of AZD1390 or a structurally related compound AZD0156 on innate immune signaling and found that both inhibitors enhanced radiation-induced Type I interferon expression via the POLIII/RIG-I/MAVS pathway.